Haleos Labs Ltd. Share Price

Overview

Haleos Labs Ltd. share price is currently ₹1,464.00, down by - ₹132.24 (8.28%) from its previous closing price of ₹1,596.24. The share price has declined -1.72% over the past month and gained 0% over the past year. The stock's 52-week low and high are ₹1,239.27 and ₹1,751.41, respectively. Haleos Labs Ltd. has a market capitalisation of ₹ 460.00 Cr. The share price was last updated on 23 Oct 2026, 03:30 PM IST.

Haleos Labs Ltd.
Haleos Labs Ltd.
HALEOSLABS
 ₹0.00
- ₹132.24
8.28%
Healthcare
 ₹0.00(%)1D

Updated: 23 Oct 2026, 03:30:01 pm IST

Market Data

Open Price

 ₹1,563.68

Prev. Close

 ₹1,596.24
 ₹1,434.34

Day Low

 ₹1,563.68

Day High

 ₹1,239.27

52 Week Low

 ₹1,751.41

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryMicro Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

28.00

Sector PE

42.08

PB Ratio

2.07

Sector PB

5.48

EPS

52.28

Dividend Yield

0.13

Today's Volume

3.121 K

5 Day Avg. Volume

1.418 K

PEG Ratio

-2.01

Market Cap.

₹ 460.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 15% at ₹1.5/Share
23-Sep-202623-Sep-2026
DividendsFinal Dividend of 15% at ₹1.5/Share
24-Sep-202524-Sep-2025
DividendsFinal Dividend of 15% at ₹1.5/Share
23-Sep-202424-Sep-2024

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Haleos Labs Ltd. 👋

Haleos Labs Limited is an India-based company. The Company is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with all types of organic & inorganic chemicals, pharmaceuticals, active pharmaceutical ingredients (API) and intermediates. It caters to both domestic and international markets, with its product portfolio comprising established products such as Ranitidine hydrochloride (HCL) and Famotidine, along with other APIs and intermediates. Its products include Ranitidine HCl (Form-2) USP/EP/IP, Famotidine USP/EP/IP, Sildenafil Citrate USP/EP/IP, Allopurinol USP/EP/IP, Ropivacaine HCl USP/EP/IP, Dapsone USP/EP/BP, Sibutramine HCl USP, Itraconazole USP/EP, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP/IP, Tiagabine HCl USP, Albendazole USP/EP/IP, Fosaprepitant Dimeglumine, Hydroxyzine HCl USP/EP/IP, Trazodone HCl USP/EP/IP, and others.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Manjushri Sharma SEBI RA

Manjushri Sharma SEBI RA

7 Aug • 12:09 AM · SEBI-Registered Analyst

Hindustan Aeronautics Limited (HAL) witnessed an impressive rally of nearly 300 points (around 6%) in a single trading session

HALEOSLABS
The primary catalyst behind the rally was the company's better-than-expected quarterly results . HAL reported healthy growth in revenue and profitability, reflecting strong execution of its defence projects and reinforcing confidence in its long-term earnings potential. Positive earnings surprises often encourage institutional investors to increase their exposure, leading to significant buying interest. From a technical perspective, HAL had been consolidating within a long-term symmetrical triangle .Today's strong bullish candle pushed the stock towards the upper boundary of this pattern, signalling renewed buying momentum. If the stock sustains above this resistance in the coming sessions, it could confirm a long-term bullish breakout. Another important factor was institutional buying . Large green candles with strong closing prices generally indicate participation from FIIs, DIIs, mutual funds, and other institutional investors rather than retail traders. The broader outlook for the defence sector also remains favourable. Government initiatives such as Atmanirbhar Bharat , rising defence capital expenditure, and increased focus on indigenous manufacturing continue to strengthen the long-term growth prospects of companies like HAL. While today's rally reflects strong market confidence, investors should avoid chasing momentum purely out of fear of missing out (FOMO). Instead, it is prudent to watch whether HAL sustains above its key resistance levels with healthy trading volumes. Confirmation of the breakout could pave the way for further upside, whereas a failure to hold above resistance may result in a temporary pullback. HAL's sharp rise was not merely a one-day price spike—it was a reflection of improving fundamentals, institutional conviction, and a technically significant breakout attempt, making it one of the most closely watched defence stocks in the current market environment.

See More
Kulneet singh

Kulneet singh

3 Aug • 7:46 PM · SEBI-Registered Analyst

India's Defence Sector Remains in Focus Amid Rising Government Orders

India's defence sector continues to attract investor attention as the government's focus on indigenous manufacturing and higher capital expenditure strengthens growth prospects for domestic defence companies. Over the past few months, the Ministry of Defence has awarded several contracts to Indian manufacturers under the 'Make in India'initiative, boosting order books across the sector. Companies involved in defence equipment, electronics, missiles, warships, and aerospace are expected to benefit from sustained government spending. A healthy order pipeline improves revenue visibility, supports long-term earnings growth, and enhances business stability. Investors are also optimistic about increasing defence exports, which have reached record levels in recent years. The sector remains one of the key long-term themes for the Indian market, supported by policy reforms, import substitution, and modernization of the armed forces. While short-term price movements may remain volatile, companies with strong execution capabilities and robust order books are likely to remain in focus. Learning Outcome: When analyzing defence companies, investors should look beyond quarterly profits and evaluate order book size, execution capability, export opportunities, and government policy support. A strong order book often indicates stable future revenue and long-term growth potential.

BEL
COCHINSHIP
DATAPATTNS
ASTRAZEN
MAZDOCK
#DEFENCE #MARKETINSIGHT #HAL #EQUITYRESEARCH #FUNDAMENTALANALYSIS

See More
Nikita (SEBI RA)

Nikita (SEBI RA)

18 Jun • 9:37 AM · SEBI-Registered Analyst

“Why Market Leaders Reveal the Direction of the Trend”

Strong stocks or sectors often lead the market before the broader trend becomes obvious. What market leaders show: Relative strength during corrections Faster recovery after declines Stronger breakout performance Learning: Leaders move first. The rest of the market often follow

CIPLA

See More
Sumit Kadam

Sumit Kadam

15 Jun • 9:34 AM · SEBI-Registered Analyst

When a Company Sells Its Biggest Business to Fund a Bigger Dream - What AXISCADES’ $206 Million Deal Teaches Every Investor

Understanding how strategic divestments help companies pivot from low margin services to high value manufacturing businesses helps investors identify transformational corporate restructuring events that create significant long term value. AXISCADES Technologies sold its Aerospace Engineering Services business to Switzerland-based Akkodis for $206.3 million - stock jumped 4% hitting upper circuit as investors cheered this massive transformation! Think of this like a student who was earning money doing homework for others - but decided to stop and build their own startup instead. AXISCADES was selling engineering services to others. Now it is using that money to build its own aerospace and defence products - a far more valuable business! The aerospace business contributed 31% of total revenue - yet the company chose to sell it. Why? Because $206.3 million will fully fund its Power 930 plan targeting ₹9,000 crore revenue and ₹960 crore profit by FY2030! Deal is structured in two tranches - Akkodis acquires 51% first with remaining 49% over next 24-30 months. This transforms AXISCADES into a products and IP-focused manufacturing platform across aerospace defence space semiconductors and AI! These are not recommendations - only learning examples.

AXISCADES
HAL
BEL
BHEL
COCHINSHIP
When a company sells a profitable division always ask - what will they do with the money? If the answer is fund a higher growth business the divestment creates far more value than the business being sold! Understanding how strategic divestments of lower margin service businesses fund higher value IP-driven manufacturing platforms helps investors identify transformational corporate pivots that create significant long term shareholder value in aerospace and defence sectors.

See More
SHUBINVESTS I SEBI RA

SHUBINVESTS I SEBI RA

12 May • 6:46 PM · SEBI-Registered Analyst

🚀 Why Are Defence Stocks Becoming Long-Term Investor Favorites in 2026?

Defence stocks continue attracting strong investor attention in 2026 as India’s focus on defence manufacturing, exports, and indigenisation keeps accelerating. Even during market volatility, many defence companies are outperforming broader indices. 1. Strong Government Push for “Make in India” India is aggressively increasing domestic defence manufacturing to reduce import dependency. This creates long-term business opportunities for Indian defence companies. 2. Record Defence Production & Exports India’s defence production crossed record levels, while exports also continued growing strongly. Rising global demand for Indian defence equipment is improving investor confidence. 3. Massive Order Books Companies like HAL, BEL, Bharat Dynamics, and Cochin Shipyard have strong order pipelines extending for several years. Long-term visibility is one of the biggest positives investors track in infrastructure and defence businesses. 4. Sector Showing Relative Strength Even during broader market volatility, defence stocks have shown strong relative performance due to structural growth expectations and rising institutional interest. • Order Book Size — Future revenue visibility • Government Contracts — Business stability • Export Growth — Global competitiveness • EBITDA Margins — Operational efficiency When analysing defence companies, investors should focus on long-term order visibility, government policy support, export growth, and execution capability because defence businesses often create value over multiple years rather than short-term quarters. Tagged Stocks: HAL

HALEOSLABS
BEL
RRKABEL
BDL
BDL
COCHINSHIP
COCHINSHIP

See More

Frequently Asked Questions

What is the share price of Haleos Labs Ltd.?

What is the market cap of Haleos Labs Ltd.?

Should I buy Haleos Labs Ltd. stock now?

What is the 52 week high and low of Haleos Labs Ltd.?

Is the Haleos Labs Ltd. stock good to buy?

Is Haleos Labs Ltd. a good buy for the long term?

Is Haleos Labs Ltd. overvalued or undervalued?

What is the PE and PB ratio of Haleos Labs Ltd.?

Start Now